Aurum Labs Receives CDPHE Certification and is Poised to be the First DEA Registered Cannabis & Hemp Testing Laboratory in the Nation
DURANGO, Colorado, August 12, 2021: Aurum Labs (https://aurum-labs.com/) is now certified by the Colorado Department of Public Health and Environment (CDPHE) to conduct hemp compliance testing for manufactured industrial hemp products and is in the final stages of Drug Enforcement Agency (DEA) registration. ISO Accredited and a leader in cannabis and hemp testing since 2014, Aurum Labs is expected to be the first testing lab to be both DEA registered and Colorado State Certified.
“Aurum has always been at the forefront of cannabis and hemp testing. We strive to meet and exceed the requirements of the state, ISO, and the federal government by innovating quickly,” says Aurum’s Owner and Lab Director Luke Mason. “Being nimble makes it possible for us to get certified by the state while simultaneously working our way through DEA registration.”
The CDPHE’s Industrial Hemp Lab Certification is the first of its kind for any state and Aurum Labs is one of only two CDPHE Certified Hemp Testing Labs in the nation. Colorado is requiring industrial hemp manufacturers and wholesalers to conduct a robust suite of compliance tests that includes potency, microbial contaminants, pesticides, heavy metals, residual solvents, and mycotoxins. This panel of tests is required for industrial hemp products intended for human consumption which is anything ingested or applied topically. Aurum Labs adheres to the most stringent hemp testing lab standards in the nation.
The process to become DEA registered poses additional challenges because of Aurum Labs’ classification as a Colorado Marijuana Testing Facility. With Schedule I substances on premises, Aurum had to postpone DEA inspection to avoid potential criminal charges and is now navigating a more rigorous registration process.
Current DEA registered labs received approval because they were either new to cannabis and hemp testing or they recently opened a new location without Schedule I substances already on site. Registering operational labs with cannabis samples on site has forced the DEA to redesign how they register existing labs, putting Aurum at the center of this groundbreaking development.
“The CDPHE hemp testing requirements are the most extensive in the nation and we are excited to provide this quality of testing to the national market ahead of federal regulations,” says Liz Mason, Aurum Labs’ Director of Operations. “I believe that our DEA registration will be a testament to our commitment to the hemp industry. We want to continue to provide comprehensive compliance testing to an industry that is still managing risk in a turbulent legal environment.”
About Aurum:
Aurum Labs is one of the most experienced analytical cannabis and hemp testing laboratories in the country. Aurum provides fast, accurate and affordable results with outstanding customer service. Aurum’s commitment to integrity and consumer safety set Aurum apart from other labs and clients receive an honest, collaborative approach to testing.
Learn more at https://aurum-labs.com/
Media Contact:
Rachel Frederico
Aurum Labs
970-422-1867 X1
rfrederico@aurum-labs.com
BDS Analytics Expands GreenEdge™ Retail Cannabis Sales Tracking Platform to Include Arizona Medical Dispensaries
Cannabis Data and Market Intelligence Leader, BDS Analytics, Expands GreenEdge™ Retail Sales Tracking Platform to Include Arizona Medical Dispensaries
BOULDER, Colo. — July 16, 2018 — BDS Analytics, the leader in comprehensive, actionable and accurate cannabis market intelligence and consumer research, today announced that the company has added the Arizona market to their state-of-the-art GreenEdge™ Retail Sales Tracking Platform. In addition to existing data from Colorado, California, Oregon and Washington, GreenEdge will now feature Arizona medical dispensary point-of-sales data dating back to January 2017.
GreenEdge provides clients access to the most accurate and actionable data available on what is selling, when, where and for how much on a daily, weekly, monthly, quarterly and annual basis. Companies can leverage real data to make strategic decisions that will advance the financial goals of their business and gain an understanding of the cannabis markets – from what is selling in different states to pricing strategies, brand concentration, market segmentation, how trends flourish over time and more.
“We are thrilled to expand our data tracking efforts into Arizona, a state that saw the first three months of 2018 bring in $160 million in sales,” said Liz Stahura, president and co-founder of BDS Analytics. “With 130 medical dispensary licenses and 115 currently operational locations, we’re confident Arizona’s medical market will continue to grow and that our clients should be paying attention to the state’s cannabis industry.”
In 2010, Arizona legalized medical marijuana after previously failed attempts. In 2017 alone, Arizona’s cannabis industry directly created 6,779 full-time positions and 9,435 employment opportunities. According to The State of Legal Marijuana Markets, Sixth Edition report recently published by Arcview Market Research in partnership with BDS Analytics, by 2022, the estimated number of legal Arizona consumers is on track to reach 508,378, driving $1.19 billion in state revenue.
“In an industry where so much is still unknown due to prohibition, access to accurate market data is an absolute must for the cannabis industry to move forward effectively,” said Aaron Smith, executive director of the National Cannabis Industry Association. “NCIA members are investing in work that will ultimately end the failed policies of prohibition and allow our industry to reach its full potential. We are proud to work with BDS Analytics to provide our membership with this invaluable tool to help them gain a competitive advantage in Arizona and beyond.”
As part of an ongoing strategic partnership, all registered NCIA members will receive access to the newly released Arizona data along with their existing access to GreenEdge™ sales data from Colorado, California, Oregon and Washington.
About BDS Analytics:
Headquartered in Boulder, Colo., BDS Analytics provides businesses with comprehensive, actionable, and accurate cannabis market intelligence and consumer research. The company provides a holistic understanding of the cannabis market by producing insights from dispensary point-of-sale systems through its market-leading GreenEdgeTM platform, driving consumer research with its Cannabis Insights Group, and generating market-wide cannabis industry financial projections. To learn more about how you can utilize BDS Analytics’ superior market research, please visit www.bdsanalytics.com.
###
Media Contact:
Carrie Booze
North 6th Agency (for BDS Analytics)
212-334-9753 ext.142
bdsanalytics@n6a.com
Follow NCIA
Newsletter
Facebook
Twitter
LinkedIn
Instagram
News & Resource Topics
–
This Just In
Committee Blog: Cannabis and Cardiovascular Disease
Rooted in Community: Fox Rothschild